Lohi J, Korhonen M, Leivo I, Kangas L, Tani T, Kalluri R, Miner J H, Lehto V P, Virtanen I
Institute of Biomedicine, Department of Anatomy, University of Helsinki, Finland.
Int J Cancer. 1997 Jul 3;72(1):43-9. doi: 10.1002/(sici)1097-0215(19970703)72:1<43::aid-ijc6>3.0.co;2-4.
Type IV collagen trimer is a major component of basement membranes (BMs). It is composed of polypeptides named alpha1(IV)-alpha6(IV) chains. Chains alpha1,2(IV) are widely expressed in BMs while alpha3(IV)-alpha6(IV) are more restricted in human tissues. We have now studied by immunohistochemical means the distribution of collagen IV chains in fetal and adult human kidney, in oncocytomas, in renal cell carcinomas (RCCs) and their metastases and in experimental xenografts of human tumors. alpha1,2(IV) chains were found in all BMs of fetal and adult kidney as well as of renal tumors, while alpha3(IV)-alpha6(IV) chains were found in BMs of distal segments of developing and mature tubules. alpha3(IV)-alpha5(IV) chains were seen also in BMs of developing fetal glomeruli after the capillary loop stage. Most of the RCCs and their metastases showed occasional expression of alpha3(IV)-alpha6(IV) with papillary variants showing only expression of alpha5(IV) chain. There was a distinct expression of alpha3(IV)-alpha5(IV) chains in BMs of 3 oncocytomas. In 2 of them a variable expression of the alpha6(IV) chain was seen. In 3 of 4 xenografts, immunoreactivity for human-specific monoclonal antibody (MAb) for alpha1,2(IV) was seen in the BM-like structures. No alpha3-alpha6(IV) was seen in any of the xenografts, while polyclonal antiserum for type IV collagen presented immunoreactivity in BMs of all xenografts. Our results show that oncocytomas and most of the RCCs express scarce variants of type IV collagen containing alpha3(IV)-alpha6(IV) chains. In experimental xenograft tumors, both implanted RCC cells and host stromal cells have a capacity to produce type IV collagen.
IV型胶原三聚体是基底膜(BMs)的主要成分。它由名为α1(IV)-α6(IV)链的多肽组成。α1、2(IV)链在基底膜中广泛表达,而α3(IV)-α6(IV)链在人体组织中的表达则更为局限。我们现在通过免疫组织化学方法研究了IV型胶原链在胎儿和成人肾脏、嗜酸性细胞瘤、肾细胞癌(RCCs)及其转移灶以及人类肿瘤实验性异种移植中的分布。在胎儿和成人肾脏以及肾肿瘤的所有基底膜中均发现了α1、2(IV)链,而在发育中和成熟肾小管远端节段的基底膜中发现了α3(IV)-α6(IV)链。在毛细血管袢期后的发育中的胎儿肾小球基底膜中也可见α3(IV)-α5(IV)链。大多数肾细胞癌及其转移灶偶尔表达α3(IV)-α6(IV),乳头状变体仅表达α5(IV)链。在3例嗜酸性细胞瘤的基底膜中有α3(IV)-α5(IV)链的明显表达。其中2例可见α6(IV)链的可变表达。在4例异种移植中的3例中,在类基底膜结构中可见针对α1、2(IV)的人特异性单克隆抗体(MAb)的免疫反应性。在任何异种移植中均未见到α3-α6(IV),而IV型胶原的多克隆抗血清在所有异种移植的基底膜中均呈现免疫反应性。我们的结果表明,嗜酸性细胞瘤和大多数肾细胞癌表达含有α3(IV)-α6(IV)链的IV型胶原的稀少变体。在实验性异种移植肿瘤中,植入的肾癌细胞和宿主基质细胞都有产生IV型胶原的能力。